Improvement Of Inactivated Equine Herpes Virus-1 Vaccine Using Carbomer | ||||
| Journal of Applied Veterinary Sciences | ||||
| Article 4, Volume 6, Issue 1, January 2021, Page 21-27 PDF (548.75 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/javs.2021.140080 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Safaa A. Warda1; Naglaa I. Ali2; Fatma F. Warda3; Ekbal M. Farouk  4; Lubna F. Farahat5
| ||||
| 1Department of Equine Vaccines Research, Veterinary Serum and Vaccine Research Institute (VSVRI), Agricultural Research Center (ARC), Egypt | ||||
| 2Department of Pet Animal Vaccines Research, Veterinary Serum and Vaccine Research Institute (VSVRI), Agricultural Research Center (ARC), Egypt. | ||||
| 3Department of Equine Vaccines Research, Veterinary Serum and Vaccine Research Institute (VSVRI), Agricultural Research Center (ARC), Egypt. | ||||
| 4Department of Foot and Mouth Disease Vaccine Research, Veterinary Serum and Vaccine Research Institute (VSVRI), Agricultural Research Center (ARC), Egypt. | ||||
| 5Department of Sera and Antigens Research, Veterinary Serum and Vaccine Research Institute (VSVRI), Agricultural Research Center (ARC), Egypt. | ||||
| Abstract | ||||
| An inactivated Equine herpes virus-1 vaccine was successfully improved using carbomer as adjuvant inducing high and long immunity in vaccinated mares in comparison with the convention one adjuvanted with Al-hydra gel and saponin. Such purpose was established by using 0.5% carbomer as adjuvant to the inactivated EHV-1. The applied quality control tests carried out on such vaccine revealed that it is free from foreign contaminants, safe in pregnant mares and mice and potent induced high levels of specific EHV-1 antibodies in vaccinated Guinea pigs and mares as measure by ELISA and SNT. This immunity was sufficient to protect vaccinated horses up to 28 weeks (7months) post-vaccination. | ||||
| Keywords | ||||
| Carbomer; ELISA; SNT; Inactivated EHV-1; Equine Virus | ||||
| References | ||||
|
ALLEN, G. P.; KYDD, J. H.; SLATER, J. D. AND SMITH, K. C. 1998. Advancesin understanding of the pathogenesis, epidemiology and immunologicalcontrol of equine herpesvirus abortion. In: Equine Infectious Diseases,
ANDERSON, E. C.; MASTER, R. C. AND MOWAT, G. N. 1971. Immune response of pigs of inactivated foot-and-mouth disease vaccines. Response to DEAE-Dextran and saponin adjuvated vaccines & quote; Res. Vet. Sci.; (12): 351-357
BERNHARDT, D. 1993. In vitro diagnosis of EHV (EHV-1 and EHV-4) Tieroriztliche Umschau, 48(2): 67-68, 70-72.
DALIA NASER 2017. Study the effect of different adjuvants on inactivated equine herpes virus – 1 vaccine. M.Sc. Virology, Fac. Science, Al-Azhar.Uni.
DIAMANTSTEIN T, WAGNER B, BEYSE I, ODENWALD MV, AND SCHULZ G. I. 1971. Stimulation of humoral antibody formation by polyanions. The effect of polyacrylic acid on the primary immune response in mice immunized with sheep red blood cells. Eur J Immunol, 1; 335-340
EMAN, M. EBEID; NASHWA, K. MADKOUR; NEHAL,S. SALEH; SAFAA, A.WARDA; ESKANDER,N.B; MAGDA,A. KALAD ANDSOLIMAN, I.M.A.2013. Effect of Quillaja saponaria Molina extract on Equine influenza and Equine Herpes virus -1. Zag. Vet.J.Vol. 41 No. 4 (2013) pp 158-165.
GUO, P., GOEBEL, S., DAVIS, S., PERKUS, M. E., LANGUET, .,DESMET'RAE, P., ALLEN, G. P. AND PAOLETRT, E. 1989. Expression in recombinant vaccinia virus of the equine herpesvirus 1 gene encoding glycoprotein gpl3 and protection of immunized animals. Journal of Virology 63, 4189-4198.
HAMDY ABD EL-RAHMAN, 2016. Preparation of inactivated EHV-1 with different adjuvants, Ph. D. Thesis; Immunology, Fac. Vet. Med. Alexandria Univ.
HASSANEIN, MM; MAYSA, H.; EL-BAGOURY, F.; MAGDA, A.K.; EL-KABBANY, M.M.A. AND DAOUD, M.A. 2002. Trials for isolation and identification of equine herpesvirus abortion in Egypt. Vet. Med. J., Giza, 50 (4): 977-986.
HENNINGER, R. W.; REED, S. M. AND SAVILLE, W. J.(2007. Outbreak of neurologic disease caused by equine herpesvirus-1 at a university equestrian center. J Vet Intern; (21):157–165.
JACQUELINE GELFI, MICHAEL PAPPALARDO, CARINE CLAVERYS, BRIGITTE PERALTA AND JEAN-LUC GUERIN (2010): Safety and efficacy of an inactivated Carbopol adjuvanted goose hemorrhagic polyomavirus vaccine for domestic geese. Avian Pathology, 39 (2), 111-116 .
KIRISAWA, R.; TERADA, M.; SEKIYA, N; KAWAKAMI, Y. AND IWAI, H. 1995. Growth and potentials of attenuated strains of EHV-1 in lungs of mice. J.Vet. Med. Series b, 42 (7): 391-39.
KYDD, J.H.; WATTRANG E. AND HANNANT D. 2003. Pre-infection frequencies of equine herpesvirus-1 specific cytotoxic T lymphocytes correlate with protection against abortion following experimental infection of pregnant mares; Vet. Immunopathol. 96: 207- 217.
KYDD, J.H.; DAVIS-POYNTER NJ.; BIRCH J.; HANNANT D.; MINKE J.; AUDONNET JC.; ANTEZAK DF. AND ELLIS SA. 2006. A molecular approach to the identification of cytotoxic T-lymphocyte epitopes within equine herpesvirus-1; J. Gen. Virol. 87: 2507-2515
LARGHI, O.P. AND A.E. NEBEL, 1980. Rabies virus inactivation by binary ethylenimine: New method for inactivated vaccine production. J. Clin. Microbiol, vol.2, pp.120-122.
MAIR K H, KOINIG H, GERNER W, HOHNE A, BRETTHAUER J AND KROLL JJ. 2015. Carbopol improves the early cellular immune responses induced by the modified-live vaccine. Ingelvac PRRS((R)) MLV. Vet. Microbiol, 176:352–7.
MAYR A., THEIN, P. & AMP; SCHEID, N. 1978. Immunization experiments with inactivated EHV-1. In proceeding 4 th Int. Conf., Equine infect. Dis., Lyon edited by Bryans, J.T.and Gerber Vet. Pub. Inc. Princeton, New Jersey, P.P 57-67.
MESQUITA A L P., ANDRESSA FERRARI ARE'VALOA, DENNIS A. ZANATTOA, SAMANTHA IVE MIYASHIROA, ELENICE MARIA SEQUETIN CUNHAB , MARIA DO CARMO CUSTO'DIO DE SOUZAB, ELIANA MONTEFORTE CASSARO VILLALOBSB, CLA'UDIA MADALENA CABRERA MORIA, PAULO CE'SAR MAIORKAA, ENIO MORIA, C. 2017. Equine herpesvirus type 1 induces both neurological and respiratory disease in Syrian hamsters. Vet. Microbiol., 203,117-124.
NASHWA KM.; EMAN ME.; NEHAL SS; FATMA FY.; EL-KABBANY MMA AND SOLIMAN I.M.A. 2016. Duration of immunity induced by combined vaccine against equine influenza and equine herpesvirus-1, VMJG, 62: 1110-1423.
NEHAL, S. SALEH,,2006. Preliminary trials for production of equine viral abortion inactivated vaccine. Ph. D. Thesis, virology, Benha Univ.
NAGLAA I. ALY, OMAIMA A. EL-SHAMANDY, SHENDY, M.B; FATMA F. WARDA; AND EKBAL, M. FAROUK, 2020. Efficacy of using Carbopol as an adjuvant for Tissue Culture Inactivated Rabies Vaccine. Journal of Applied Veterinary Sciences, 5(3): 103 – 107.
OIE. 1990. Equine rhinopneumonites. Manual of standards diagnostic tests and vaccines. 2nd edition chapter 2-5-9 pp 1-6.
OIE .201. Equine rhinopneumonites. Manual of standards diagnostic tests and vaccines. 8th edition chapter 2-5-9 pp 1-13.
OIE. 2019. Equine rhinopneumonites . Manual of standards diagnostic tests and vaccines. Chapter 12-8.
PAILLOT, R.; CASE, R.; ROSS, J.; NEWTON, R. AND NUGENT, J. 2008. Equine Herpes Virus-1: Virus, Immunity and Vaccines. Veterinary Science Journal; 2: 68-91.
POUWELS, H. G. W., BSC, VAN DE ZANDE, S. M. A., DVM, PH.D., DIP. ECPVS, HORSPOOL, L. J. I., BVMS, PH.D., DIP. ECVPT, MRCVS, AND HOEIJMAKERS, M. J. H., MSC. 2014. Efficacy of a non-updated, Matrix-C-based equine influenza subunit-tetanus vaccine following Florida sublineage clade 2 challenge. Vet Rec. Jun; 174(25): 633.
REED, L.T AND MUNECH, H. 1938. A simple method of estimating 50 %end points. Am., J. Hyg., 27: 493.
SAFAA, A. WARDA; TARADI, A. SAID AND DAOUD, A.M. 2005. Trials for preparation and evaluation of locally prepared polyclonal immune serum against EHV.4th Int. Sci. Conf. Mansoura Univ., 477-486.
SAFAA, A. W. 2007. Adaptation of locally isolated EHV-1 on different cell line. 5th Int. Sci. Conf. Beni Suef Vet. Med.: 52-60.
SAFAA A. WARDA AND HUSSIN, M. G. 2012. Immune response of horses vaccinated with tissue culture inactivated EHV – 1 oil Montanide ISA70 adjuvanted vaccine. Egypt J. Agric, Res; 90(3), 1309 - 1321.
SHANKER, H. AND YADAV, M. P. 1986. Occurrence of paralytic syndrome in equines due to equine Herpes virus – 1 Rev. Sci, Tech, Off. Int. Epiz., 5 (1): 15-21
SCHWABE, C.W., RIEMANN, H. AND FRANTI, F. 1977. Epidemiology in veterinary practice. 1st Ed. Lee and Febiger,PhiladelphiaSuGiura, T.; Kondo, T.; Matsumura, T.; Imagawa, H.;Kamada, M. and Ihara, T. (1997): Evaluation of enzyme-linkedimmunosorbent assay for titration of antibodies to EHV-1. J. Equine Sci., 3 (8): 57-61.
SLATER, I.D.; GIBSON J.S. AND FIELD, H. J. 1993. Pathogenicity of thymidine kinase-deficient mutant of EHV-1 in mice and specific pathogen-free foals, J. Gen Virol., 74(5): 819-828.
SUGIURA T.; KONDO T.; MATSUMURA T.; IMAGAWA H.; KAMADA M. AND IHARA T. 1997. Evaluation of enzyme-linked immunosorbent assay for titration of antibodies to EHV-1, J. Equine Sci. 8 (3): 57-61.
United States Pharmacopeial Convention (1990): Carbomer. Inc. Rockville, Maryland, 1911.
WOOD JM.; MUMFORD J.; FOLKERS O.; SEOTT AM, SCHILD GC. 1983. Studies with inactivated equine influenza vaccine. 1. Serological responses of ponies to graded doses of vaccine. J Hyg. 1983: 90: 371-84. | ||||
|
Statistics Article View: 527 PDF Download: 642 |
||||
